Identifying pathogenic proteins leads to potential new treatments for diseases such as diabetes.

Published Date: 02 Mar 2023

New research has identified hundreds of proteins that can lead to the development of metabolic diseases, such as type 2 diabetes mellitus, and therefore have treatment potential.

Read Full News

Latest News

Sleeve Gastrectomy and Hernia Repair Hold Up Long Term

Sleeve gastrectomy with hiatal hernia repair shows acceptable long-term outcomes, with postoperative reflux symptoms being associated with recurrence and need for reintervention.

Liver Steatosis Common in Women Referred for PMOS

A study of young women referred for PMOS finds high rates of liver steatosis, while commonly used screening tools miss most cases of liver fibrosis.

Menopausal Hormone Therapy Tied to Risk for Eye Misalignment

Menopausal hormone therapy is linked to increased risks for diagnosis of and surgery for strabismus, and researchers detect estrogen receptor alpha in the human eye muscle.

Constipation Common but Rarely New in GLP-1 Users

Constipation is already prevalent in patients with obesity initiating GLP-1 therapy, but only a small proportion develop new symptoms after beginning treatment.

New AI Imaging Detects ‘Striking’ Obesity-Related Neuropathy

Fascinating nervous system imaging reveals previously unseen obesity-related nerve damage in mice and humans — and some of it may be linked to GLP-1 use.

Safe Antibiotics in Pregnancy and Breastfeeding

A new ENTIS webinar highlights evidence-based antibiotic choices in pregnancy and lactation, including when amoxicillin, fosfomycin, and macrolides can be used safely.

Todays Updates

AI-Driven Biomarker Predicts Prostate Cancer Outcomes

The tool, based on histology only, may help identify patients most likely to benefit from triplet therapy.

Community Oncology Well Suited for Advanced Cancer Patients

Experts tout common characteristics of local physician practices that are beneficial to those with advanced disease.

Todays Updates

AI-Driven Biomarker Predicts Prostate Cancer Outcomes

The tool, based on histology only, may help identify patients most likely to benefit from triplet therapy.

Community Oncology Well Suited for Advanced Cancer Patients

Experts tout common characteristics of local physician practices that are beneficial to those with advanced disease.

Latest News

Sleeve gastrectomy with hiatal hernia repair shows acceptable long-term outcomes, with postoperative reflux symptoms being associated with recurrence and need for reintervention.

A study of young women referred for PMOS finds high rates of liver steatosis, while commonly used screening tools miss most cases of liver fibrosis.

Menopausal hormone therapy is linked to increased risks for diagnosis of and surgery for strabismus, and researchers detect estrogen receptor alpha in the human eye muscle.

Constipation is already prevalent in patients with obesity initiating GLP-1 therapy, but only a small proportion develop new symptoms after beginning treatment.

Fascinating nervous system imaging reveals previously unseen obesity-related nerve damage in mice and humans — and some of it may be linked to GLP-1 use.

A new ENTIS webinar highlights evidence-based antibiotic choices in pregnancy and lactation, including when amoxicillin, fosfomycin, and macrolides can be used safely.

News All Time

BMI Extremes Tied to Worse Pregnancy Outcomes With ART

BMI appears to have a greater impact on pregnancy continuation than on achieving initial implantation or pregnancy. Study findings suggest promoting proactive BMI optimization before treatment.

India's New Transgender Rules Worry Doctors, Disrupt Care

Mehr Khan, an Indian transgender woman, arrived for a routine hormone therapy appointment only to discover the crucial treatment had been suspended after a recent change in the law.

Kailera Shares Tumble on High Nausea Rates Despite Weight-loss Drug's Success

Kailera Therapeutics' shares dropped 10% on Tuesday after its oral weight-loss drug showed high rates ⁠of nausea and vomiting among participants in a late-stage trial in...

Pharmacist-Led Outreach Improves SGLT2 Inhibitor Uptake

Patients with chronic kidney disease and type 2 diabetes receiving pharmacist-led outreach were nearly twice as likely to start an SGLT2 inhibitor as those receiving usual care.

EMA Fast-tracks Review Of Revolutions' Experimental Pancreatic Cancer Pill

The European Medicines Agency said on Tuesday it has begun a rolling review of Revolution ⁠Medicines' experimental treatment for patients with metastatic pancreatic...

Cortisol Normalises by 4 Weeks After Stopping Contraceptives

Serum corticosteroid-binding globulin and total cortisol levels decrease rapidly and normalise within 4 weeks after the cessation of combined oral contraceptives, a Dutch study shows.

Middle-of-the-Night Eating Skews the Gut’s Circadian Clocks

Off-schedule eating disrupted intestinal circadian clocks in mice, which may help explain digestive and metabolic issues in night-shift workers.

Can Elevated MMP12 Levels Predict Pancreatic Cancer Risk?

Increased MMP12 levels are associated with a higher risk for pancreatic cancer, especially among patients diagnosed within 4 years of blood collection for immune marker analysis, a study reports.

Obesity Drugs Work Best for Youth With Lifestyle Support

The combination of obesity drugs with structured lifestyle programs ranks highest for yielding the greatest weight loss in children and adolescents, a network meta-analysis finds.

The Evolving Role of Non-Oral Contraceptive Strategies in Patient-Centered Care

The Evolving Role of Non-Oral Contraceptive Strategies in Patient-Centered Care

Current Evidence and Clinical Considerations in Non-Oral Contraceptive Care

Current Evidence and Clinical Considerations in Non-Oral Contraceptive Care

Navigating New Guidelines and Evidence in MASH: Noninvasive Assessments and Individualized Care

Navigating New Guidelines and Evidence in MASH: Noninvasive Assessments and Individualized Care

Navigating Advances in Obesity Management: Amylin-Biology and Emerging Therapeutic Approaches

Navigating Advances in Obesity Management: Amylin-Biology and Emerging Therapeutic Approaches

Unproven Peptides Need More Regulation, AMA Delegates Say

Let's "separate the science from the snake oil," says delegate

Drug Fights GLP-1 Muscle Loss; Unapproved Retatrutide Prescriptions; Protein Swap

News and commentary from the endocrinology world

Oral Small-Molecule Elecoglipron Tackles Obesity and Diabetes

Investigational pill was well-tolerated and doesn't come with food or water restrictions

Recommended News For You

Silibinin is a novel and ancient molecule that highlights the significance of integrated therapies for cancer.

Anti-PD-L1 Plus Targeted Agent No Better Than Chemo for Resistant NSCLC

High Success Rate With Conversion Therapy for Unresectable Gastroesophageal Cancer

Encounters matter in cancer care: Health care professionals can play a key role in restoring patients' sense of control

High weight and obesity are associated with poor outcomes in leukemia treatment.

Committee Recommends Canada Not Permit Euthanasia Solely for Mental Illness

Report reveals lung cancer is the leading cause of cancer deaths in Florida

Recommended Articles For You

The Unfolding Revolution of Precision Medicine, Immunotherapy, and Digital Transformation in Medical Oncology 2025 

Targeted Therapy: Latest Advances, Learning Tools, Trials & Treatment Options Explained 

PARP Inhibitors in Testicular Cancer: Tackling Cisplatin Resistance with Precision 

Engineered Red Blood Cell Therapeutics: Emerging Applications 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

EVP Beats Cisplatin for Resectable MIBC

2.

After three years, responses to mounetuzumab in follicular lymphoma are still stable.

3.

In NPM1-mutated acute myeloid leukemia, MRD Correlates with Allo-Transplant Benefit.

4.

Chronic stress and obesity work together to accelerate pancreatic cancer development and growth, study finds

5.

A three-quarters reduction in the risk of prostate cancer is associated with an annual increase in cardiorespiratory fitness of more than three percent.

1.

Exploring the Potential of Xospata: A New Frontier in Cancer Treatment

2.

Prognostic Role of PLAU in Pan-Cancer and Neutrophil Infiltration in Bladder Cancer

3.

CAR T-Cell Therapy: Revolutionizing Hematologic Malignancies

4.

Navigating the Challenges of Vaso-Occlusive Crisis: A Guide for Patients and Caregivers

5.

Managing High Potassium Levels: A Comprehensive Guide to Veltassa 

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part II

2.

Navigating the Complexities of Ph Negative ALL - Part X

3.

Post Progression Approaches After First-line Third-Generaion ALK Inhibitors

4.

Dacomitinib Case Presentation: Baseline Treatment and Current Status

5.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot